Key Factors Involved in Efferocytosis
1. Introduction
The development of the mammary gland occurs in four distinct phases: embryogenesis, puberty, pregnancy, and a post-lactational phase involving profound levels of cell death and tissue remodeling. This post-lactational phase is termed post-lactational involution. During embryogenesis, a solid epithelial bud is generated in the embryonic ectoderm. As this bud continues to grow in cell number, the epithelial bud invaginates into the underlying mesenchyme forming the nascent mammary epithelium. The mammary epithelium grows as solid epithelial cords, lengthening distally and branching to form the rudimentary epithelial network. At puberty, ductal elongation continues in a proximal-to-distal direction, and side branches appear along the ducts. The side branches also lengthen distally, and continue to branch. This pattern of distal growth and branching fills the mouse mammary fat pad with an extensively branched epithelium by the end of puberty [6]. Similar to what is seen during embryonic mammary development and patterning, the mammary ducts developing during puberty originally appear in solid epithelial cords. Apoptosis canalizes the luminal space within the ducts, allowing a patent conduit for milk to traverse through the breast epithelium [1, 7]. Ultimately, the rodent mammary epithelium is comprised of a continuous, branching network leading from the nipple to primary ducts and smaller ductules that terminate in terminal end buds (TEBs), blunt ends or alveoli. The inner luminal cells are separated from the basement membrane by an outer myoepithelial layer. Myoepithelial cells secrete basement membrane components to which the epithelium attaches, and that physically separates the epithelium from the stromal compartment.
Many morphological similarities exist between the mouse mammary gland and the human breast, although some distinctions exist. In the human breast, the cluster of epithelial acini arising from a single terminal duct, referred to as the terminal duct lobular unit (TDLU), is thought to be the milk-producing unit of the mammary gland. Therefore, the post-pubertal human breast harbors cells capable of milk production even in the absence of pregnancy whereas the rodent mammary gland does not. However, profound expansion and differentiation of the TDLU population in the human breast is still required in order to render lactation successful.
This expansion of the alveolar epithelium during pregnancy occurs in response to both local and systemic factors that drive mammary alveolar proliferation. In rodents, the entire secretory epithelium of the mammary gland develops during the gestation period of approximately three weeks, signifying a rapid 10-fold increase in epithelial content of the mammary gland. The mammary gland produces colostrum and then milk upon partuition. However, once offspring are weaned, the milk-producing lobuloalveolar cells are no longer necessary. Rather than being maintained, these secretory cells undergo programmed cell death in an exquisitely controlled and rapid process, while leaving the ductal epithelium intact. Dying cells are cleared from the post-lactational mammary gland rapidly and without causing acute inflammation, removing up to 90% of the total mammary epithelial content within the time span of just one week in rodent models. This returns the mammary gland to an almost pre-pregnant state, so that the changes in the mammary gland that accompany pregnancy, lactation and involution may again occur with each successive pregnancy.
The process of involution is complex requiring two distinct phases, the initiation of extensive cell death to remove the milk-producing epithelial cells, followed by the controlled influx of macrophages and other immune cell types to breakdown extracellular matrix, remodel blood vessels, replenish the adipocyte population in the mammary fatpad, and to phagocytically remove dead cells, residual milk, and debris. This review will focus primarily on the events controlling cell death that occur within the first days of post-lactational involution.
2. Body
2.1. Signaling mechanisms that control post-lactational apoptosis in the breast
In recent years, molecular regulation of post-lactational involution has been studied primarily in the mouse mammary gland, due in large part to the relatively rapid gestation and nursing period in mice, and to the extensive use of genetically engineered mouse models. These models, coupled with advances in transcriptional profiling have provided a detailed analysis of the dynamic cellular and molecular events occurring during the earliest days of involution, when the majority of programmed cell death occurs.
2.2. Milk stasis
Using teat-sealing to block milk delivery in a single mouse mammary gland, investigators demonstrated that a complex multi-step process initiating massive epithelial apoptosis is triggered by local stimuli produced in the sealed mammary gland, but not by changing levels of circulating hormones that are available to the remaining nine mouse mammary glands [8, 9]. These studies revealed that milk stasis is a primary trigger of post-lactational cell death in the mammary gland [8]. Accumulation of milk within the secretory luminal space might initiate cell death by causing a mechanical stretch of these cells, or of cell-cell junctions [10]. It is clear that mechanical stress, including cell stretching, can initiate biological responses in several epithelial and endothelial cell types, and may activate signaling pathways known to trigger cell death in the post-lactational mammary gland. For example, cell stretching induces STAT3 phosphorylation, inhibition of the survival factor AKT, and expression of Leukemia Inhibitory Factor (LIF), each of which are critical during early post-lactational involution for the induction of cell death, as discussed below. Another potential explanation of milk stasis-induced cell death is that accumulation of milk components, such as calcium, may trigger cell death [11]. In support of this hypothesis, transcription of the plasma membrane protein calcium-ATPase 2 (PMCA2), which transports 60–70% of milk calcium [12], is dramatically and rapidly reduced during involution, perhaps due to self-limiting negative feedback in an effort to control potentially toxic divalent cation levels [13]. Loss of the gene encoding PMCA2 (
2.3. STAT3
Transcriptional profiling studies of the mouse mammary gland at specific time points during lactation and post-lactational involution demonstrated that a specific subset of genes is dramatically induced within 12 hours of pup withdrawal, presumably in response to milk accumulation [4, 16]. It was hypothesized that this gene subset may represent potential ‘master regulators’ of programmed cell death in the post-lactational mammary gland. This idea has been largely confirmed using genetically engineered mouse models that disrupt key expression events, resulting in a delay in post-lactational programmed cell death.
The transcription factor Signal Transducer and Activator of Transcription (STAT) 3 was conditionally deleted in the mammary epithelium of genetically engineered mice, revealing its critical role in initiating the earliest events in post-lactational apoptosis [17-19]. While it has been known for some time that STAT3 regulates the expression of pro-inflammatory genes involved in the acute phase response (the early inflammatory response to tissue injury) [20, 21], and that many inflammation-related genes are expressed during post-lactational involution [4, 22, 23], these studies were the first to demonstrate the molecular similarities that exist between the involuting mammary gland and the traditional wound healing scenario [23], despite the fact that involution-induced transcriptional responses are directed primarily by epithelial cells, while wound healing-induced transcriptional responses are directed by cells of the immune system.
STAT3 is widely expressed, and is activated by tyrosine phosphorylation in response to numerous cytokines and growth factors [e.g. interleukin-6 (IL-6), IL-10, IL-17, IL-23, EGF] and tyrosine kinases (c-Src, Met, ErbB-2) [24]. Tyrosine phosphorylation of STAT3 allows STAT3 dimers to translocate from the cytoplasm to the nucleus, where STAT3 binds to sequence-specific DNA elements in the promoters of STAT3 target genes. STAT3 activates gene transcription of many inflammation related genes, and can also repress the transcription of others. Although STAT3 transcriptional activity is associated with cell survival in several cell types including lymphomas and solid tumor epithelial cells [25-28], STAT3 takes on a different role in the post-lactational mammary gland, where STAT3 is required to initiate cell death. In the absence of STAT3, cell death was abrogated for at least 6 days after pup withdrawal, despite milk stasis [18, 19]. Conversely, loss of suppressor of cytokine signaling (SOCS)-3, a negative regulator of STAT3, accelerated involution by increasing the rate of cell death following pup withdrawal [29, 30].
A number of genes regulated by STAT3, such as CAAT/enhancer binding protein (C/ebp)δ, oncostatin M (OSM), OSM receptor (OSMR), and insulin-like growth factor (IGF) binding protein (IGFBP)-5, are also required in the post-lactational mammary epithelium to initiate cell death [31, 32]. OSM, a cytokine normally produced by macrophages but in this case produced by the mammary epithelium, is required during post-lactational involution, since OSMR knockout mice exhibited delayed involution [33]. Loss of C/ebpδ, a transcription factor involved in the acute phase response, also delayed mammary gland involution [31]. Because STAT3, and many target genes activated by STAT3, are critical triggers of cell death during post-lactational involution, it is likely that STAT3 lies at the apex of a transcriptionally-activated signaling cascade that is required to initiate cell death in the post-lactational mammary epithelium. This role of STAT3 as an apoptosis inducer lies in contrast with observations that STAT3 is frequently activated in several cancer entities [28], correlating with heightened malignancy [34, 35]. Further, constitutive STAT3 activity promotes tumor formation in skin [36] and lung [37, 38]. The apparent discrepancy may be related to tissue specificity of STAT3 activity, or the activity of STAT3 in the tumor microenvironment (for example, in inflammatory cells) versus its role in the epithelial compartment of the tumor.
2.4. NF-κB
Although the role of STAT3 in the induction of post-lactational apoptosis is clear, STAT3 alone is insufficient to induce involution in the absence of nuclear factor-κB (NF-κB) signaling [39]. NF-κB comprises a family of five structurally and functionally related transcription factors [40]. Based on their transactivation properties, NF-κB proteins are divided into two classes: Class I consists of RelA/p65, RelB, and c-Rel, while Class II includes NF-κB1/p50 and NF-κB2/p52. Each can dimerize in almost any combination but only class I proteins possess the C-terminal transactivation domains required for NF-κB-mediated transcription of target genes. Under basal conditions, NF-κB dimers are sequestered in the cytoplasm bound to the protein Inhibitor of κB (IκB). Several signaling pathways can activate the IκB kinases (IKKs) that phosphorylate IκB, thus liberating NF-κB dimers and allowing their nuclear translocation, where they bind to specific DNA sequences in target genes.
Among this family of transcription factors, two NF-κB subunits, RelA (p65) and p50 are expressed at different levels in the mammary epithelium throughout mammary gland development. Furthermore, NF-κB activity as measured
2.5. Akt/PI3K
Intense interest in survival signaling pathways has revealed that phosphatidyl inositol 3-kinase (PI3K) is a potent regulator of cell survival [50, 51]. Cancer cells frequently utilize PI3K signaling to promote cell survival under conditions of hypoxia, nutrient stress, or even to escape the cytotoxic effects of therapeutic anti-cancer treatments. It is clear, however, that non-transformed cells also use the PI3K signaling pathway to promote cell survival, and that increased PI3K signaling can interfere with physiological cell death [52]. PI3K is a heterodimer comprised of p110 (the catalytic domain) and p85 (the regulatory domain) [50, 53]. Under basal conditions, p85 represses the catalytic activity of p110. However, SH2 domains in p85 interact with phosphorylated tyrosines within YxxM motifs of receptor tyrosine kinases (RTKs) such as the insulin-like growth factor (IGF)-1 receptor (IGFR) or adaptor proteins, such as the insulin receptor substrate proteins. This relieves p85-mediated inhibition of p110, allowing p110 to phosphorylate phosphatidyl inositol 2-phosphate (PIP2), thus generating PIP3, a powerful membrane-associated second messenger that recruits pleckstrin homology (PH)-domain containing proteins to the cell membrane. PDK1 and Akt are two PH-domain containing proteins recruited to the membrane in response to RTK activation [52, 54, 55]. PDK1 is a serine-threonine kinase that phosphorylates Akt, another serine-threonine kinase that stimulates cell survival by interacting with members of the Bcl2 family of apoptosis regulators [56-58], which are also involved in the induction of cell death during involution [59-61]. For example, mammary-specific loss of the Bcl2 family member Bax, a known cell death inducer, decreased apoptosis during early involution [60, 62-64], while overexpression of Bax within the secretory mammary epithelium increased post-lactational apoptosis and promoted precocious STAT3 activity [7, 65]. Loss of the anti-apoptotic protein Bcl-xL in the mammary gland during post-lactational involution accelerated cell death [66, 67]. By inactivating Bax and activating Bcl-xL, Akt activity increases cell survival in the secretory mammary epithelium.
The role of PI3K/Akt signaling in suppressing post-lactational apoptosis is supported by genetically engineered mouse models that result in increased PI3K/Akt signaling. For example, a mouse model in which mammary-specific expression of myristoylated p110α [68], a modified p110α that is restricted to the cell membrane, resulted in aberrantly elevated PI3K activity in the mammary epithelium and delayed post-lactational involution. Similarly, mammary-specific transgenic overexpression of Akt1 or Akt2 promoted cell survival and delayed post-lactational involution in mice [69, 70]. Conversely, ablation of Akt1, but not the ablation of Akt2 or Akt3, promoted apoptosis and accelerates involution [71], demonstrating isoform-specificity in the gene-dosage effects of Akt (overexpression versus ablation), and highlights the importance of Akt1 in the post-lactational mammary gland. Other studies demonstrated that Akt signaling is sustained during lactation by prolactin signaling [72-74]. This observation was confirmed in an independent transgenic mouse model of mammary-specific STAT5 activation, in which STAT5 activity, when aberrantly sustained through post-lactational involution, upregulated Akt1 transcription and impaired apoptosis. These studies suggest that high levels of prolactin-induced STAT5 activity, as seen during lactation, maintains Akt1 expression and activity to promote cell survival, but when lactation ceases STAT5-induced Akt expression must be depleted in order for cells to undergo apoptosis [75].
Like prolactin signaling, other ligand-activated signaling cascades are capable of driving PI3K/Akt signaling during lactation, and if not turned off, can delay post-lactational apoptosis. For example, cell signaling initiated by IGF-1, which activates IGFR thus causing tyrosine phosphorylation of insulin receptor substrate proteins [76], potently activates the PI3K/Akt signal transduction cascade in the mammary epithelium during lactation. Overexpression of IGF-1 in the mouse mammary gland delayed post-lactational involution, suggesting that suppression of IGF-mediated cell survival is required for apoptosis to occur, and supporting the idea that PI3K signaling must be interrupted to initiate post-lactational apoptosis [77]. IGF-1 bio-availability is tightly controlled by IGF binding proteins (IGFBPs), which can sequester IGFs in the extracellular microenvironment of the mammary epithelium [78]. Consistent with the ability of IGF-1 to interfere with post-lactational cell death, one of the earliest transcriptional events during post-lactational involution is the upregulation of IGFBP-2 mRNA (4-fold), IGFBP-4 (6-fold) and IGFBP-5 mRNA (50-fold) [79]. This profound increase in IGFBP-5 is also seen at the protein level, and is conserved across several species. Increased expression of IGFBPs may limit IGF1-induced signaling, thus limiting IGF1-induced PI3K/Akt signaling [77, 80, 81]. Transgenic overexpression of IGFBP-5 in the mouse mammary gland increased caspase-3 cleavage (an indicator of apoptosis) and decreased the expression of the pro-survival factors Bcl-2 and Bcl-xL [80-84], suggesting that IGFBP-5 is pro-apoptotic. An IGF-1 analogue which binds weakly to IGFBP-5 partially overcame IGFBP-5-induced cell death during post-lactational involution, suggesting that IGFBP-5 was acting, at least in part, by inhibiting IGF action. Conversely,
2.6. TGFβ3
While prolactin, IGF-1, and several RTK-activating ligands can activate PI3K/Akt signaling to promote cell survival, other ligands are capable of inducing cell death during post-lactational involution, such as leukemia inhibitor factor (LIF) [85-87], serotonin [88], Fas ligand (FasL) [89] TRAIL [90], and transforming growth factor (TGF)-β3. Transcripts encoding TGF-β3, but not TGF-β1 or TGF-β2, substantially increase in the milk-producing cells during post-lactational involution [91, 92]. This rapid induction of TGF-β3 transcription in the secretory mammary epithelium occurs as early as 3 hours after pup withdrawal in response to milk stasis [93], and is among the most rapid gene expression changes occurring in response to post-lactational involution, suggesting that TGFβ3 might be an initiating signal for cell death during involution. It would be interesting to determine the impact of mechanical stress on expression from the TGFβ3 promoter. Consistent with the proposed role for elevated TGF-β3 in inducing apoptosis during involution, transgenic over-expression of TGF-β3 in the secretory cells of the mouse mammary gland accelerated apoptosis during early post-lactational involution. Conversely, loss of TGFβ3 reduced post-lactational apoptosis by nearly 70% [93], suggesting that autocrine TGF-β3 signaling initiates cell death following pup removal.
The importance of the TGFβ3-induced signaling pathway for post-lactational apoptosis has been further investigated in genetically engineered mouse models. For example, loss of the TGFβ-regulated transcription factor Smad3 decreased post-lactational apoptosis by nearly 40% [94]. Similarly, loss of TGF-β receptor type II (TβRII) in the mammary epithelium, or transgenic expression of dominant negative (DN) TβRII decreased apoptosis during early post-lactational involution [95-97], consistent with a critical role for TGF-β3 signaling through TβRII and Smad3 to induce apoptosis during early involution. However, there is some discrepancy regarding the role of TGFβ signaling during involution, as transgenic expression of constitutively active TβRI decreased apoptotic cells in the mammary gland [98]. Perhaps elevated TβRI signaling activates signaling pathways not normally active under physiological conditions.
2.7. Stromal-epithelial interactions
The signaling pathways described above focus on those events occurring within the secretory epithelium that are responsible for initiating cell death during post-lactational involution. However, it is becoming more apparent that stromal cells contribute substantially to post-lactational apoptosis [99-103]. This was recently demonstrated in a transgenic mouse model referred to as MAFIA (macrophage Fas-induced apoptosis) [104]. Macrophages from MAFIA mice express a modified Fas receptor that, in response to a dimerization-inducing small molecule (AP20187), triggers Fas-mediated apoptosis. Depletion of macrophages immediately prior to weaning impaired apoptosis within the secretory mammary epithelium, despite milk stasis and STAT3 activation [105]. These results demonstrate that macrophages are necessary to initiate apoptosis in the mammary epithelium. The underlying mechanism remains unclear at this point. However, it is possible that macrophages respond to signals emanating from mechanically stressed epithelia by producing factors that may activate the signaling pathways necessary for induction of apoptosis, or repress signaling pathways that may otherwise limit apoptosis. The transcriptional signatures generated from mouse mammary glands during involution were derived from whole tissue RNA, which would include not only epithelia but also the dynamic stromal components of the mammary gland. Therefore, it is possible that many expression events detected during early post-lactational involution are occurring within macrophage populations.
Mast cells are also heavily recruited to the mammary gland during post-lactational involution [106], and like macrophages, are critical for epithelial apoptosis during mammary gland involution [107]. Specifically, mast cells produce plasma kallikrien (PKaI), the primary activator of plasminogen in the mammary gland. Expression of PKaI rapidly increases during involution, and while PKaI, plasminogen, and other serine proteases undoubtedly have a major role in tissue remodeling during later stages of involution, evidence suggests that PKaI also drives epithelial apoptosis. Inhibition of mast cell-derived PKaI during post-lactational involution impaired epithelial cell death, suggesting that mast cells are vital for triggering apoptosis in the post-lactational mammary gland. Interestingly, in the absence of STAT3 within the mammary epithelium, mast cells and macrophages are not recruited to the mammary gland during post-lactational involution [108], suggesting that recruitment of stromal cells to the involuting mammary gland is initiated by early apoptotic signaling events occurring within the epithelial compartment (Fig. 1).
2.8. Lysosomal membrane polarization
Although most studies suggest that mammary gland involution occurs by apoptosis, it has been proposed recently that several morphological features of the involuting mammary gland may resemble necrosis rather than apoptosis [109]. These include cytoplasmic swelling, lack of membrane blebbing, and lack of nuclear fragmentation. Using mice deficient for both caspase 3 and 6, it was shown that mammary gland involution could proceed in the absence of these two classical activators of apoptosis, suggesting that perhaps alternative mechanisms of programmed cell death may exist in the post-lactational mammary gland. The authors proposed that STAT3 activity could upregulate expression of lysosomal cathepsins, which may leak from lysosomes to activate cell death pathways [110, 111]. In support of this idea, cathepsin L is upregulated strongly with the onset of mammary involution [112]. Mice treated with a specific cathepsin L inhibitor during the first three days of involution demonstrated reduced cell death as compared to untreated mice [112]. Cathepsin-induced cell death can be simulated by ectopic addition of reactive oxygen species (ROS) to cultures of mammary epithelial cells. Interestingly, the ROS nitric oxide (NO) can trigger mammary gland involution after weaning [113] in mice. While the role of apoptotic cell death in the mammary gland is widely accepted, investigators should be aware of alternative cell death pathways that contribute to programmed cell death during involution.
2.9. Pathologies of the breast due to aberrant regulation of apoptosis
In the clinical setting, post-lactational involution of the secretory epithelium begins with milk stasis, at which point the secretory cells undergo apoptosis. Clearance of dying cells and residual milk is accomplished by phagocytes within the breast [114]. Regrowth of stromal adipose tissue and continued tissue remodeling returns the breast to a relatively quiescent state comprised of morphological structures similar to those found in nulliparous women. Rarely, the process of involution may be delayed. Failure to remove unnecessary lactational cells may result in symptomatic inflammatory tissue damage. Delayed involution in the human breast is characterized by the maintenance of secretory structures, loss of post-lactational apoptosis, and infiltration of the breast by inflammatory cells. Focal calcification may also be present [5]. Ductal distention of accumulated milk can be painful. Stagnant milk can be a source for infection and mastitis, to which the gland would respond with secretion of acute inflammatory cytokines and recruitment of leukocytes [115]. Similar to this clinical scenario, mouse models of delayed post-lactational cell death commonly develop mastitis [49, 108, 116].
PSR | - | PS [117] | Primary mouse mammary epithelia [117] | |
TIMs | - | PS [118-124] | unknown | |
BAI1 | - | PS [125] | unknown | |
Stabilin-2 | - | PS [126, 127]. | unknown | |
ABCA1 | unknown | PS [128, 129] | Bovine [130], mouse, human mammary [129] | |
αvβ3 integrin | Vitronectin [131] Thrombospondin [132] MFG-E8 [133] | PS [131, 132] | Human MCF10A, MCF-7, and MDA-MB-231 cells [134] bovine [135], mouse mammary gland [136, 137] | |
Tyro3 | Gas6 [138] Protein S [139, 140] | PS [138] | unknown | |
Axl | Gas6 [138, 141] | PS [138, 141] | Human breast [142] | |
MerTK | Gas6 [138] Protein S[140] | PS [138, 140] | Mouse mammary [116] | |
CR3/CR4 | unknown | C3bi [143] | unknown | |
CD14 | unknown | ICAM [144] | Bovine [145], canine [146], mouse [4], and human mammary [144, 147] | |
CD68 | unknown | unknown | Human, mouse mammary macrophages [148] | |
CD163 | unknown | unknown | Human breast [148] | |
CD36 | Thrombospondin [132] | unknown | MDA-MB-435, MDA-MB-231 human cells in mouse mammary [149] | |
LRP | β2GP1 [150] C1q [151] | PS [150] Calreticulin [151] | Rat mammary gland [152] Normal, transformed mammary epithelia [153] | |
Marco [154] | unknown | unknown | unknown |
Recent data garnered from mouse models of delayed post-lactational involution suggest that deregulation of post-lactational apoptosis may facilitate mammary tumor formation [34, 70, 73, 155-157]. Observations made in human populations also suggest that altered post-lactational involution may associate with tumor formation in the breast [100-102, 158]. This may reflect micro-environmental influences, or may be a function cell death-dependent removal of unnecessary breast epithelial cells in a regulated fashion. In many cancers, intrinsic cell deaths mechanisms become suppressed, contributing to the net growth of the transformed cell population. For example, activation of STAT5 in post-lactational mouse mammary glands delays apoptosis, and results in formation of mammary tumors that express estrogen and progesterone receptors (ER+PR+), as well as activated STAT3 and STAT5 [159]. Moreover, post-lactational transcriptional programs initiated by NF-κB and STAT3 not only support cell death, but also enhance tumor formation and progression by inducing expression of pro-tumorigenic cytokines [23, 24, 28, 34, 160-162]. Indeed, the transiently increased risk of developing breast cancer in the five years following a pregnancy may be greatly influenced by a deregulated tumor microenvironment developed in the post-lactational breast [101].
While post-lactational involution and age-related lobular involution are distinct processes, recent studies indicate that both are related to breast cancer development. Clinical studies show that completion of lobular involution may reduce future breast cancer incidence [163-166]. With aging, there is a gradual loss of breast epithelial tissue that typically begins in peri-menopause, which then accelerates during menopause. Lobular involution is characterized by the apoptosis-mediated decrease in the size and complexity of the ductal tree and of the TDLU. This is distinct from post-lactational involution, which occurs very rapidly by comparison. However, similar mechanisms controlling apoptosis of the breast epithelium may occur in these two distinct models of involution.
Lobular involution, like post-lactational involution, may inversely correlate with breast cancer risk, since premenopausal women who underwent partial or complete lobular involution had a substantially decreased incidence of breast cancer, while postmenopausal women who showed delayed lobular involution were found to have a correspondingly elevated breast cancer incidence [164]. While much remains to be learned about how lobular involution is regulated, some clinical studies and animal models suggest that IGF-1 may inhibit involution of lobules in the breast [163]. Clinically, a cross-sectional study among 472 women demonstrated that higher IGF-1 levels associated with incomplete lobular involution, supporting the idea that IGF-1/PI3K/Akt-induced survival pathways prevent physiologic cell death, leading to pathological consequences.
2.10. Introduction to efferocytosis in the breast
Following apoptosis, one final event is needed to truly complete the life of the cell. This final step is phagocytic engulfment of apoptotic cells or ‘efferocytosis’. The term ‘efferocytosis’ was recently coined by Hensen et al. to distinguish phagocytic apoptotic cell removal from phagocytic pathogen removal [167]. While both processes are executed by phagocytes, they result in distinctly different biological responses, one characterized by a dampened acute inflammatory response and upregulation of tolerogenic and wound healing effectors (efferocytosis), while the other is characterized by a pro-inflammatory response (pathogen removal).
Efferocytosis is a carefully regulated process involving recruitment of phagocytes to the apoptotic cell, recognition of the apoptotic cell by the phagocytes, engulfment of the apoptotic cell by the phagocyte, and final breakdown of apoptotic cell components. If disrupted, apoptotic cells will undergo necrotic lysis, leading to acute inflammation, tissue damage and autoimmunity. Therefore, efferocytosis is critical for tissue homeostasis. However, recent discoveries indicate that the normal process of efferocytosis may be undesirable under certain pathological conditions, such as in the tumor microenvironment. We will discuss apoptotic cell clearance in the normal post-lactational breast and in the breast tumor microenvironment.
2.11. The process of efferocytosis
In general, clearance of apoptotic cells is often executed by macrophages and dendritic cells (DCs), but can also be performed by fibroblasts, endothelial and epithelial cells. A cell that engulfs an apoptotic cell through phagocytic mechanisms is called an efferocyte, regardless of its origin. Studies performed in cell culture and
Macrophages, the ‘professional phagocytes’ of the immune system, must infiltrate the mammary gland in response to the physiological presence of apoptotic cells during involution. Large quantities of bone marrow-derived and spleen-derived macrophages infiltrate the post-lactational mouse mammary gland in response to STAT3 activation and apoptosis of the mammary secretory epithelium. It is thought that apoptotic cells may release soluble chemo-attractants, or ‘find me’ signals, which recruit macrophages to the post-lactational mammary gland. For example, Monocyte Chemo-attractant Protein-1 (MCP-1/CCL2) is released from apoptotic cells in an NF-κB-dependent manner [169]. Interestingly, MCP-1 expression is strongly induced in the mammary gland at day 2 of involution, a time point that follows NF-κB-induced cell death, and that precedes macrophage influx in the post-lactational mammary gland. These observations are consistent with NF-κB-induced apoptosis followed by NF-κB-induced expression of an efferocyte chemo-attractant, although this has not yet been demonstrated. Additional chemokines including CX3CL1, CCL6, CCL7, CCL8, and CXCL14, are induced during post-lactational involution and may be signals that recruit macrophages to the involuting mammary gland to clear the accumulating apoptotic cell burden [170, 171] [4, 16].
Histological evidence of apoptotic cells within cytoplasmic vacuoles of mammary macrophages confirms that mammary macrophages engulf apoptotic cells during involution. Once present within the mammary gland, the macrophage identifies apoptotic cells, scanning for signals that are present on the apoptotic cell but not a healthy cell, often referred to as an ‘eat me’ signal (EMS, Table 1). The earliest and most recognized EMS is surface exposure of phosphatidylserine (PS). Healthy cells actively maintain PS on the inner plasma membrane leaflet. At the onset of apoptosis, PS is presented to the outer leaflet thus acting as a marker for a dying cell that requires engulfment [172-174]. EMSs are recognized by macrophages that express EMS receptors on their cell surface. EMS receptors may bind directly to the EMS on the dying cell. For example, the PS receptor (PSR), a transmembrane protein expressed by macrophages [128] and MECs [129], directly binds PS. Brain angiogenesis inhibitor 1 (BAI1) also binds PS directly, and is important for macrophage-mediated efferocytosis [125], but has not yet been studied in the mammary gland. Stabilin-2 and members of the T cell immunoglobin and mucin (TIM) family of receptors also directly bind PS [118-124, 126, 127], demonstrating mechanistic redundancy in the efferocytic pathways. It should be noted, however, that PS is an insufficient EMS, as macrophages fail to recognize live cells in which PS is forced to the outer leaflet [173, 175].
While some EMS receptors bind apoptotic cell EMSs directly, other EMS receptors bind an extracellular bridging molecule that simultaneously binds the EMS and the EMS receptor (Table 1). For example, the bridging ligand milkfat globule epidermal growth factor-like 8 (MFG-E8) binds to PS on apoptotic cells [133, 176, 177], while binding αvβ3 and αvβ5 integrins expressed by macrophages. Growth arrest specific gene 6 (Gas6) and Protein S [178, 179] are bridging molecules that bind to the EMS receptors MerTK, Axl, and Tyro3 [180] expressed by macrophages, while simultaneously binding PS on the apoptotic cell.
Once the apoptotic cell is bound to the macrophage, intracellular signaling pathways must remodel the actin cytoskeleton to drive phagocytic ingestion of the apoptotic cell. Most of these events have been mapped out in
In addition to efferocytosis in the mammary gland, macrophages are also critical for cytokine modulation and extracellular matrix remodeling during the second phase of involution, underscoring the important role of macrophages in the post-lactational breast. Given their known role as professional phagocytes and their massive influx to the post-lactational mammary gland, it is perhaps not surprising that efferocytosis by macrophages occurs in the post-lactational breast. What is more surprising is that apoptotic cell clearance occurs on a profound scale prior to the influx of macrophages to the involuting mammary gland. Recent evidence demonstrated that MECs are the primary efferocytes of the breast during the earliest stages of post-lactational involution, the first three days prior to the influx of macrophages. The ability of MECs to act as efferocytes ensures a rapid response to the massive level of apoptosis that occurs during post-lactational involution. Loss of MEC-mediated efferocytosis impairs post-lactational homeostasis, resulting in chronic mammary inflammation, scarring and inhibition of future lactation.
Interestingly, MECs utilize many of the same EMS receptors used by macrophages to recognize apoptotic MECs. For example, MerTK is critical for MEC-mediated efferocytosis during post-lactational involution. MerTK loss from the mouse mammary epithelium causes apoptotic cell accumulation and milk stasis [116], despite the presence of wild-type macrophages. Interestingly, mRNA and protein expression of MerTK is dramatically upregulated by post-lactational day 1 within the luminal mammary epithelium. Similarly, the integrins αvβ3 and αvβ5 are expressed in the early post-lactational mammary epithelium. The αvβ5 bridging ligand, MFG-E8, is simultaneously induced [194], increasing the physical interaction between MFG-E8 and PS [136] and driving the clearance of membrane-coated milk components from the involuting mammary gland [195].
2.12. Physiological and pathological consequences of efferocytosis
After the efferocyte removes the apoptotic cell, transcriptional events in the efferocyte result in cytokine, chemokine and growth factor production. The combined profile of the factors produced by the efferocyte promotes wound healing through enhanced tissue remodeling, angiogenesis, proliferation and resolution of acute inflammation. The efferocytosis-induced wound healing cytokine profile contrasts sharply to the cytokine profile produced in response to phagocytosis of pathogens, which is characterized by acute inflammatory cytokines [196]. In fact, efferocytosis is thought to be a key step in resolving or dampening acute inflammatory cytokine expression following tissue injury or pathogen exposure, resulting in repair and homeostasis [197]. Microarray analyses of mammary glands harvested at early post-lactational involution time points displayed a pronounced wound healing expression signature [3, 4, 158, 168, 198, 199], consistent with transcriptional changes that result from efferocytosis. The prominent role of efferocytosis in re-establishing mammary homeostasis following widespread apoptosis of the secretory epithelium was shown by experiments in which loss of efferocytosis resulted in apoptotic cell accumulation, sustained milk stasis within ductal lumens, inflammation and scarring [116]. These pathological changes impaired lactation in future pregnancies.
Although key to re-establishing homeostasis in the post-lactational mammary gland [116], recent evidence indicates that efferocytosis may support a more malignant tumor microenvironment [101, 102, 105, 106, 158, 198, 200-202]. Researchers are beginning to address the overlapping roles of efferocytic and metastasis-promoting cytokines. In agreement with this idea, mouse studies show that breast tumors grew more rapidly, invaded more readily, and formed distant metastases more efficiently when implanted in the post-lactational mammary gland as compared to implantation into a nulliparous mammary gland [101]. One explanation for this observation is that post-lactational efferocytosis promotes breast tumor malignancy through production of wound healing cytokines, which are known to drive breast cancer growth and invasion. In support of this idea, MFG-E8 [203] and its receptor αvβ3/5, as well as Gas6 and its ligand MerTK [116, 204] are frequently overexpressed in breast cancers. One recent study demonstrated that the pro-tumorigenic cytokine IL-6 induces expression of MerTK, enhancing the ability of macrophages to engulf apoptotic cells and increasing production of wound healing cytokines such as IL-4 and IL-10 [205]. Recently published data implicates MerTK in breast cancer metastasis [206].
This observation has clinical relevance to pregnancy associated breast cancers (PABCs), defined as breast cancers that arise during the 5 years following a pregnancy. PABCs are among the most malignantly aggressive breast cancers, and are thus associated with poor prognosis. A better understanding of the processes outline above will undoubtedly expand the therapeutic options for these patients.
3. Conclusion
Altogether, these data support the hypothesis that targeting mediators of efferocytosis may limit pro-tumorigenic cytokine production. Moreover, it is becoming increasingly apparent that many factors within the mammary gland cooperate to ensure apoptosis and apoptotic cell clearance, highlighting the complexity of these processes and the need for more detailed investigations. Due to the dominant role of apoptosis and efferocytosis in maintaining tissue homeostasis, especially during post-lactational involution, the mammary gland provides an ideal platform for future study.
AcknowledgementThis work was supported by NIH R01 CA143126 (RSC), and Susan G. Komen KG100677 (RSC).
References
- 1.
Apoptosis in the terminal endbud of the murine mammary gland: a mechanism of ductal morphogenesis. Development,Humphreys R. C et al 1996 4013 4022 - 2.
Apoptosis in the estrous and menstrual cycles. J Mammary Gland Biol Neoplasia, andAndres A. C R Strange 1999 221 228 - 3.
Roles of the innate immune system in mammary gland remodeling during involution. J Mammary Gland Biol Neoplasia,Atabai K andD Sheppard Z Werb 2007 37 45 - 4.
Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3. Breast Cancer Res,Stein T et al 2004 R75 R91 - 5.
Phagocytosis of apoptotic cells: a matter of balance. Cell Mol Life Sci, andDe Almeida C. J R Linden 2005 1532 1546 - 6.
Key stages in mammary gland development: the mammary end bud as a motile organ. Breast Cancer Res, andHinck L G. B Silberstein 2005 245 251 - 7.
BIM regulates apoptosis during mammary ductal morphogenesis, and its absence reveals alternative cell death mechanisms. Dev Cell,Mailleux A. A et al 2007 221 234 - 8.
Mammary-derived signals activate programmed cell death during the first stage of mammary gland involution. Proc Natl Acad Sci U S A,Li M et al 1997 3425 3430 - 9.
Milk accumulation triggers apoptosis of mammary epithelial cells. Eur J Cell Biol,Marti A et al 1997 158 165 - 10.
Mechanical strain induces involution-associated events in mammary epithelial cells. BMC Cell Biol,Quaglino A et al 2009 55 - 11.
Calcium sensing by the mammary gland. J Mammary Gland Biol Neoplasia,Vanhouten J. N 2005 129 139 - 12.
The calcium-sensing receptor regulates plasma membrane calcium adenosine triphosphatase isoform 2 activity in mammary epithelial cells: a mechanism for calcium-regulated calcium transport into milk. Endocrinology,Vanhouten J. N andM. C Neville J. J Wysolmerski 2007 5943 5954 - 13.
PMCA2 regulates apoptosis during mammary gland involution and predicts outcome in breast cancer. Proc Natl Acad Sci U S A,Vanhouten J et al 2010 11405 11410 - 14.
Local control of mammary involution: is stanniocalcin-1 involved? J Dairy Sci,Tremblay G et al 2009 1998 2006 - 15.
Nuclear targeting of stanniocalcin to mammary gland alveolar cells during pregnancy and lactation. Am J Physiol Endocrinol Metab,Hasilo C. P et al 2005 E634 E642 - 16.
Gene expression profiling of mammary gland development reveals putative roles for death receptors and immune mediators in post-lactational regression. Breast Cancer Res,Clarkson R. W et al 2004 R92 109 - 17.
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol,Chapman R. S et al 2000 129 138 - 18.
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev,Chapman R. S et al 1999 2604 2616 - 19.
Deletion of Stat3 blocks mammary gland involution and extends functional competence of the secretory epithelium in the absence of lactogenic stimuli. Endocrinology,Humphreys R. C et al 2002 3641 3650 - 20.
Activation of Stat3 by receptor tyrosine kinases and cytokines regulates survival in human non-small cell carcinoma cells. Oncogene,Song L et al 2003 4150 4165 - 21.
Jr., Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science,Zhong Z andZ Wen J. E Darnell 1994 95 98 - 22.
Stat3 and the inflammation/acute phase response in involution and breast cancer. J Mammary Gland Biol Neoplasia,Pensa S andC. J Watson V Poli 2009 121 129 - 23.
Stat3 regulates genes common to both wound healing and cancer. Oncogene,Dauer D. J et al 2005 3397 3408 - 24.
Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann N Y Acad Sci,Aggarwal B. B et al 2009 59 76 - 25.
Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma. Blood,Aoki Y andG. M Feldman G Tosato 2003 1535 1542 - 26.
STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene,Kanda N et al 2004 4921 4929 - 27.
Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. Immunity,Catlett-falcone R et al 1999 105 115 - 28.
Stat3 as an oncogene. Cell,Bromberg J. F et al 1999 295 303 - 29.
Knocking off SOCS genes in the mammary gland. Cell Cycle,Sutherland K. D andG. J Lindeman J. E Visvader 2007 799 803 - 30.
c-myc as a mediator of accelerated apoptosis and involution in mammary glands lacking Socs3. EMBO J,Sutherland K. D et al 2006 5805 5815 - 31.
C/EBPdelta is a crucial regulator of pro-apoptotic gene expression during mammary gland involution. Development,Thangaraju M et al 2005 4675 4685 - 32.
Comparison of mammary gland involution between 129S1 and C57BL/6 inbred mouse strains: differential regulation of Bcl2a1, Trp53, Cebpb, and Cebpd expression. Oncogene,Thangaraju M andS Sharan E Sterneck 2004 2548 2553 - 33.
A dual role for oncostatin M signaling in the differentiation and death of mammary epithelial cells in vivo. Mol Endocrinol,Tiffen P. G et al 2008 2677 2688 - 34.
Stat3 promotes metastatic progression of prostate cancer. Am J Pathol,Abdulghani J et al 2008 1717 1728 - 35.
Identification of a Stat3-dependent transcription regulatory network involved in metastatic progression. Cancer Res,Ranger J. J et al 2009 6823 6830 - 36.
Stage-specific disruption of Stat3 demonstrates a direct requirement during both the initiation and promotion stages of mouse skin tumorigenesis. Carcinogenesis,Kataoka K et al 2008 1108 1114 - 37.
Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell. DNA Cell Biol,Yeh H. H et al 2009 131 139 - 38.
Autocrine IL-6-induced Stat3 activation contributes to the pathogenesis of lung adenocarcinoma and malignant pleural effusion. Oncogene,Yeh H. H et al 2006 4300 4309 - 39.
IKKbeta/2 induces TWEAK and apoptosis in mammary epithelial cells. Development,Baxter F. O et al 2006 3485 3494 - 40.
Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol, andKarin M Y Ben-neriah 2000 621 663 - 41.
Dynamic expression and activity of NF-kappaB during post-natal mammary gland morphogenesis. Mech Dev,Brantley D. M et al 2000 149 155 - 42.
The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med,Li Z. W et al 1999 1839 1845 - 43.
IKKbeta is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFalpha. Immunity,Maeda S et al 2003 725 737 - 44.
IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis. Immunity,Senftleben U et al 2001 217 230 - 45.
a target of AKT in anti-apoptotic PDGF signalling. Nature, andRomashkova J. A S. S Makarov N. F-k. a. p. p. a. B Is 1999 86 90 - 46.
Stabilization ofFujioka S et al 53 is a novel mechanism for proapoptotic function of NF-kappaB. J Biol Chem,2004 p. 27549-59. - 47.
Death receptors: signaling and modulation. Science, andAshkenazi A V. M Dixit 1998 1305 1308 - 48.
Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression. J Immunol,Baetu T. M et al 2001 3164 3173 - 49.
Activation of nuclear factor kappa B in mammary epithelium promotes milk loss during mammary development and infection. J Cell Physiol,Connelly L et al 2010 73 81 - 50.
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet,Engelman J. A andJ Luo L. C Cantley 2006 606 619 - 51.
Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev,Wong K. K andJ. A Engelman L. C Cantley 2010 87 90 - 52.
Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts. Breast Cancer Res, andWickenden J. A C. J Watson 2010 202 - 53.
The phosphoinositide 3-kinase pathway. Science,Cantley L. C 2002 1655 1657 - 54.
AKT/PKB signaling: navigating downstream. Cell, andManning B. D L. C Cantley 2007 1261 1274 - 55.
The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer, andVivanco I C. L Sawyers 2002 489 501 - 56.
Mechanism of apoptosis induction by inhibition of the anti-apoptotic BCL-2 proteins. Proc Natl Acad Sci U S A,Chipuk J. E et al 2008 20327 20332 - 57.
Bcl-2-family proteins and the role of mitochondria in apoptosis. Curr Opin Cell Biol, andKuwana T D. D Newmeyer 2003 691 699 - 58.
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell,Datta S. R et al 1997 231 241 - 59.
Bax and Bcl-xs are induced at the onset of apoptosis in involuting mammary epithelial cells. Mech Dev,Heermeier K et al 1996 197 207 - 60.
Bcl-2 gene family and related proteins in mammary gland involution and breast cancer. J Mammary Gland Biol Neoplasia,Schorr K et al 1999 153 164 - 61.
Developmental regulation of Bcl-2 family protein expression in the involuting mammary gland. J Cell Sci,Metcalfe A. D et al 1999 Pt 11):1771 1783 - 62.
Transformation of mammary epithelial cells by 3-phosphoinositide-dependent protein kinase-1 (PDK1) is associated with the induction of protein kinase Calpha. Cancer Res,Zeng X andH Xu R. I Glazer 2002 3538 3543 - 63.
PDK1 regulates cancer cell motility by antagonising inhibition of ROCK1 by RhoE. Nat Cell Biol, andPinner S E Sahai 2008 127 137 - 64.
Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol,Alessi D. R et al 1997 261 269 - 65.
Forced involution of the functionally differentiated mammary gland by overexpression of the pro-apoptotic protein bax. Genesis, rd,Rucker E. B et al 2011 24 35 - 66.
Conditional deletion of the bcl-x gene from mouse mammary epithelium results in accelerated apoptosis during involution but does not compromise cell function during lactation. Mech Dev,Walton K. D et al 2001 281 293 - 67.
Gain of Bcl-2 is more potent than bax loss in regulating mammary epithelial cell survival in vivo. Cancer Res,Schorr K et al 1999 2541 2545 - 68.
Activation of phosphatidylinositol 3-kinase by membrane localization ofRenner O et al 110alpha predisposes mammary glands to neoplastic transformation. Cancer Res,2008 p. 9643-53. - 69.
Akt1 and akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. Cancer Res,Dillon R. L et al 2009 5057 5064 - 70.
Mammary gland involution is delayed by activated Akt in transgenic mice. Mol Endocrinol,Schwertfeger K. L andM. M Richert S. M Anderson 2001 867 881 - 71.
Distinct roles of the three Akt isoforms in lactogenic differentiation and involution. J Cell Physiol,Maroulakou I. G et al 2008 468 477 - 72.
Stat5 promotes survival of mammary epithelial cells through transcriptional activation of a distinct promoter in Akt1. Mol Cell Biol,Creamer B. A et al 2010 2957 2970 - 73.
Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Mol Endocrinol,Neilson L. M et al 2007 2218 2232 - 74.
Prolactin inhibits cell loss and decreases matrix metalloproteinase expression in the involuting mouse mammary gland but fails to prevent cell loss in the mammary glands of mice expressing IGFBP-5 as a mammary transgene. J Mol Endocrinol,Flint D. J et al 2006 435 448 - 75.
Signal transducer and activator of transcription 5 as a key signaling pathway in normal mammary gland developmental biology and breast cancer. Breast Cancer Res,Furth P. A et al 2011 220 - 76.
Targeting the insulin-like growth factor network in cancer therapy. Cancer Biol Ther,Heidegger I et al 2011 701 707 - 77.
Role of insulin-like growth factor binding proteins in mammary gland development. J Mammary Gland Biol Neoplasia,Flint D. J et al 2008 443 453 - 78.
Insulin-like growth factor binding proteins and mammary gland development. Int J Dev Biol,Sureshbabu A andE Tonner D. J Flint 2011 781 789 - 79.
Insulin-like growth factor binding proteins initiate cell death and extracellular matrix remodeling in the mammary gland. Domest Anim Endocrinol,Flint D. J et al 2005 274 282 - 80.
Insulin-like growth factor binding protein (IGFBP)-5 is upregulated during both differentiation and apoptosis in primary cultures of mouse mammary epithelial cells. J Cell Physiol,Lochrie J. D et al 2006 471 479 - 81.
Insulin-like growth factor binding protein 5 and apoptosis in mammary epithelial cells. J Cell Sci,Marshman E et al 2003 Pt 4):675 682 - 82.
Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland. Endocrinology, andAllar M. A T. L Wood 2004 2467 2477 - 83.
Insulin-like growth factor binding protein-5 (IGFBP-5) potentially regulates programmed cell death and plasminogen activation in the mammary gland. Adv Exp Med Biol,Tonner E et al 2000 45 53 - 84.
Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice. Development,Tonner E et al 2002 4547 4557 - 85.
Mouse mammary tumors display Stat3 activation dependent on leukemia inhibitory factor signaling. Breast Cancer Res,Quaglino A et al 2007 R69 - 86.
Leukemia inhibitory factor induces apoptosis of the mammary epithelial cells and participates in mouse mammary gland involution. Exp Cell Res,Schere-levy C et al 2003 35 47 - 87.
A dual, non-redundant, role for LIF as a regulator of development and STAT3-mediated cell death in mammary gland. Development,Kritikou E. A et al 2003 3459 3468 - 88.
Serotonin regulates mammary gland development via an autocrine-paracrine loop. Dev Cell,Matsuda M et al 2004 193 203 - 89.
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest,Song J et al 2000 1209 1220 - 90.
Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem J,Sohn B. H et al 2001 Pt 1):31 38 - 91.
Differential expression of TGF-beta isoforms during postlactational mammary gland involution. Cell Tissue Res,Faure E et al 2000 89 95 - 92.
Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development,Robinson S. D et al 1991 867 878 - 93.
Transforming growth factor beta3 induces cell death during the first stage of mammary gland involution. Development, andNguyen A. V J. W Pollard 2000 3107 3118 - 94.
Smad3 in the mammary epithelium has a nonredundant role in the induction of apoptosis, but not in the regulation of proliferation or differentiation by transforming growth factor-beta. Cell Growth Differ,Yang Y. A et al 2002 123 130 - 95.
Transgenic mice expressing a dominant-negative mutant type II transforming growth factor-beta receptor exhibit impaired mammary development and enhanced mammary tumor formation. Am J Pathol,Gorska A. E et al 2003 1539 1549 - 96.
Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biol Cell,Joseph H et al 1999 1221 1234 - 97.
TGF-beta promotes cell death and suppresses lactation during the second stage of mammary involution. J Cell Physiol,Bierie B et al 2009 57 68 - 98.
Activated type I TGFbeta receptor kinase enhances the survival of mammary epithelial cells and accelerates tumor progression. Oncogene,Muraoka-cook R. S et al 2006 3408 3423 - 99.
Role of mesenchymal-epithelial interactions in mammary gland development. J Mammary Gland Biol Neoplasia, andCunha G. R Y. K Hom 1996 21 35 - 100.
The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium. Epithelial Cell Biol, andHowlett A. R M. J Bissell 1993 79 89 - 101.
Postpartum mammary gland involution drives progression of ductal carcinoma in situ through collagen and COX-2. Nat Med,Lyons T. R et al 2011 1109 1115 - 102.
Alternatively activated macrophages and collagen remodeling characterize the postpartum involuting mammary gland across species. Am J Pathol, J.,O Brien et al 2010 1241 1255 - 103.
Immune cell location and function during post-natal mammary gland development. J Mammary Gland Biol Neoplasia, andReed J. R K. L Schwertfeger 2010 329 339 - 104.
Conditional macrophage ablation in transgenic mice expressing a Fas-based suicide gene. J Leukoc Biol,Burnett S. H et al 2004 612 623 - 105.
Macrophages are crucial for epithelial cell death and adipocyte repopulation during mammary gland involution. Development, J.,O Brien et al 2012 269 275 - 106.
Alterations in mast cell frequency and relationship to angiogenesis in the rat mammary gland during windows of physiologic tissue remodeling. Dev Dyn,Ramirez R. A et al 2012 890 900 - 107.
Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution. J Biol Chem,Lilla J. N et al 2009 13792 13803 - 108.
Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression. J Pathol,Hughes K et al 2012 106 117 - 109.
Stat3 controls lysosomal-mediated cell death in vivo. Nat Cell Biol,Kreuzaler P. A et al 2011 303 309 - 110.
New insights into cathepsin D in mammary tissue development and remodeling. Cancer Biol Ther,Margaryan N. V et al 2010 457 466 - 111.
Caspase-independent cell death? Oncogene, andLockshin R. A Z Zakeri 2004 2766 2773 - 112.
Cathepsin L plays an active role in involution of the mouse mammary gland. Dev Dyn,Burke M. A et al 2003 315 322 - 113.
Nitric oxide triggers mammary gland involution after weaning: remodelling is delayed but not impaired in mice lacking inducible nitric oxide synthase. Biochem J,Zaragoza R et al 2010 451 462 - 114.
Epithelial cells remove apoptotic epithelial cells during post-lactation involution of the mouse mammary gland. Biol Reprod,Monks J et al 2008 586 594 - 115.
Delayed involution of lactation presenting as a non-resolving breast mass: a case report. J Med Case Reports,Kumar Y et al 2008 327 - 116.
Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev Biol,Sandahl M et al 2010 122 - 117.
A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature,Fadok V. A et al 2000 85 90 - 118.
T cell/transmembrane, Ig, and mucin-3 allelic variants differentially recognize phosphatidylserine and mediate phagocytosis of apoptotic cells. J Immunol,Dekruyff R. H et al 2010 1918 1930 - 119.
Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J Clin Invest,Ichimura T et al 2008 1657 1668 - 120.
TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity,Kobayashi N et al 2007 927 940 - 121.
Identification of Tim4 as a phosphatidylserine receptor. Nature,Miyanishi M et al 2007 435 439 - 122.
T and B cell hyperactivity and autoimmunity associated with niche-specific defects in apoptotic body clearance in TIM-4-deficient mice. Proc Natl Acad Sci U S A,Rodriguez-manzanet R et al 2010 8706 8711 - 123.
Structures of T Cell immunoglobulin mucin receptors 1 and 2 reveal mechanisms for regulation of immune responses by the TIM receptor family. Immunity,Santiago C et al 2007 299 310 - 124.
Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages. Proc Natl Acad Sci U S A,Wong K et al 2010 8712 8717 - 125.
BAI1 is an engulfment receptor for apoptotic cells upstream of the ELMO/Dock180/Rac module. Nature,Park D et al 2007 430 434 - 126.
Epidermal growth factor-like domain repeat of stabilin-2 recognizes phosphatidylserine during cell corpse clearance. Mol Cell Biol,Park S. Y et al 2008 5288 5298 - 127.
Rapid cell corpse clearance by stabilin-2, a membrane phosphatidylserine receptor. Cell Death Differ,Park S. Y et al 2008 192 201 - 128.
The ATP binding cassette transporter ABC1, is required for the engulfment of corpses generated by apoptotic cell death. EMBO J, andLuciani M. F G Chimini 1996 226 235 - 129.
Expression, localization, and functional model of cholesterol transporters in lactating and nonlactating mammary tissues of murine, bovine, and human origin. Am J Physiol Regul Integr Comp Physiol,Mani O et al 2010 R642 R654 - 130.
Identification of ABCA1 and ABCG1 in milk fat globules and mammary cells--implications for milk cholesterol secretion. J Dairy Sci,Mani O et al 2011 1265 1276 - 131.
Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration. J Biol Chem,Yebra M et al 1996 29393 29399 - 132.
Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest,Savill J et al 1992 1513 1522 - 133.
The opsonin MFG-E8 is a ligand for the alphavbeta5 integrin and triggers DOCK180-dependent Rac1 activation for the phagocytosis of apoptotic cells. Exp Cell Res,Akakura S et al 2004 403 416 - 134.
The urokinase plasminogen activator receptor promotes efferocytosis of apoptotic cells. J Biol Chem, V.,D Mello et al 2009 17030 17038 - 135.
Characterization of glycoprotein PAS-6/7 from membranes of bovine milk fat globules. Eur J Biochem,Hvarregaard J et al 1996 628 636 - 136.
Weaning-induced expression of a milk-fat globule protein, MFG-E8, in mouse mammary glands, as demonstrated by the analyses of its mRNA, protein and phosphatidylserine-binding activity. Biochem J,Nakatani H et al 2006 21 30 - 137.
Lactation-dependent expression of an mRNA splice variant with an exon for a multiply O-glycosylated domain of mouse milk fat globule glycoprotein MFG-E8. Biochem Biophys Res Commun,Oshima K et al 1999 522 528 - 138.
Identification of the product of growth arrest-specific gene 6 as a common ligand for Axl, Sky, and Mer receptor tyrosine kinases. J Biol Chem,Nagata K et al 1996 30022 30027 - 139.
The anticoagulation factor protein S and its relative, Gas6, are ligands for the Tyro 3/Axl family of receptor tyrosine kinases. Cell,Stitt T. N et al 1995 661 670 - 140.
TAM receptor function in the retinal pigment epithelium. Mol Cell Neurosci,Prasad D et al 2006 96 108 - 141.
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6. Nature,Varnum B. C et al 1995 623 626 - 142.
Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast. Ann Oncol,Berclaz G et al 2001 819 824 - 143.
Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med,Mevorach D et al 1998 2313 2320 - 144.
Macrophage recognition of ICAM-3 on apoptotic leukocytes. J Immunol,Moffatt O. D et al 1999 6800 6810 - 145.
Proinflammatory cytokines and CD14 expression in mammary tissue of cows following intramammary inoculation of Panax ginseng at drying off. Vet Immunol Immunopathol,Baravalle C et al 2011 52 60 - 146.
Density of tumor-associated macrophages (TAMs) and expression of their growth factor receptor MCSF-R and CD14 in canine mammary adenocarcinomas of various grade of malignancy and metastasis. Pol J Vet Sci,Krol M et al 2011 3 10 - 147.
CD16+ monocytes in breast cancer patients: expanded by monocyte chemoattractant protein-1 and may be useful for early diagnosis. Clin Exp Immunol,Feng A. L et al 2011 57 65 - 148.
Expression of macrophage antigens by tumor cells. Adv Exp Med Biol, andShabo I J Svanvik 2011 141 150 - 149.
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res Treat,Koch M et al 2011 337 346 - 150.
Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J Biol Chem,Maiti S. N et al 2008 3761 3766 - 151.
Role of surfactant proteins A, D, and C1q in the clearance of apoptotic cells in vivo and in vitro: calreticulin and CD91 as a common collectin receptor complex. J Immunol,Vandivier R. W et al 2002 3978 3986 - 152.
Endoplasmic reticulum lumenal proteins of rat mammary gland. Potential involvement in lipid droplet assembly during lactation. Biochim Biophys Acta,Ghosal D andN. W Shappell T. W Keenan 1994 175 181 - 153.
In vitro invasiveness of human breast cancer cells is promoted by low density lipoprotein receptor-related protein. Invasion Metastasis,Li Y et al 1998 240 251 - 154.
A defect in Marco expression contributes to systemic lupus erythematosus development via failure to clear apoptotic cells. J Immunol,Rogers N. J et al 2009 1982 1990 - 155.
Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation ofLofgren K. A et al 38 MAPK. Breast Cancer Res,2011 p. R89. - 156.
Activation of murine double minute 2 by Akt in mammary epithelium delays mammary involution and accelerates mammary tumorigenesis. Cancer Res,Cheng X et al 2010 7684 7689 - 157.
Distinct biological roles for the akt family in mammary tumor progression. Cancer Res, andDillon R. L W. J Muller 2010 4260 4264 - 158.
Macrophages in breast cancer: do involution macrophages account for the poor prognosis of pregnancy-associated breast cancer? J Mammary Gland Biol Neoplasia,O Brien J. a. n. d P Schedin 2009 145 157 - 159.
Stat5 assumes distinct functions in mammary gland development and mammary tumor formation. Front Biosci,Vafaizadeh V andP. A Klemmt B Groner 2012 1232 1250 - 160.
Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene. Mol Carcinog,Barbieri I et al 2010 114 120 - 161.
Inhibition of NF-kappa B activity in mammary epithelium increases tumor latency and decreases tumor burden. Oncogene,Connelly L et al 2011 1402 1412 - 162.
The biological functions of the versatile transcription factors STAT3 and STAT5 and new strategies for their targeted inhibition. J Mammary Gland Biol Neoplasia,Desrivieres S et al 2006 75 87 - 163.
Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses’ Health Study II. Breast Cancer Res,Rice M. S et al 2012 R44 - 164.
Independent association of lobular involution and mammographic breast density with breast cancer risk. J Natl Cancer Inst,Ghosh K et al 2010 1716 1723 - 165.
Lobular involution, mammographic density, and breast cancer risk: visualizing the future? J Natl Cancer Inst,Gierach G. L andL. A Brinton M. E Sherman 2010 1685 1687 - 166.
Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer,Ginsburg O. M andL. J Martin N. F Boyd 2008 1369 1374 - 167.
Dampening inflammation. Nat Immunol,Henson P. M 2005 1179 1181 - 168.
Epithelial cells as phagocytes: apoptotic epithelial cells are engulfed by mammary alveolar epithelial cells and repress inflammatory mediator release. Cell Death Differ,Monks J et al 2005 107 114 - 169.
Concomitant induction of apoptosis and expression of monocyte chemoattractant protein-1 in cultured rat luteal cells by nuclear factor-kappaB and oxidative stress. Dev Growth Differ,Nagaosa K andA Shiratsuchi Y Nakanishi 2003 351 359 - 170.
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epithelium. Clin Cancer Res,Graham K et al 2011 236 246 - 171.
CX3CL1/fractalkine is released from apoptotic lymphocytes to stimulate macrophage chemotaxis. Blood,Truman L. A et al 2008 5026 5036 - 172.
Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol,Fadok V. A et al 1992 2207 2216 - 173.
Macrophage recognition of externalized phosphatidylserine and phagocytosis of apoptotic Jurkat cells--existence of a threshold. Arch Biochem Biophys,Borisenko G. G et al 2003 41 52 - 174.
Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med,Martin S. J et al 1995 1545 1556 - 175.
Calcium-dependent phospholipid scrambling by TMEM16F. Nature,Suzuki J et al 2010 834 838 - 176.
Identification of a factor that links apoptotic cells to phagocytes. Nature,Hanayama R et al 2002 182 187 - 177.
Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science,Hanayama R et al 2004 1147 1150 - 178.
Cell adhesion to phosphatidylserine mediated by a product of growth arrest-specific gene 6. J Biol Chem,Nakano T et al 1997 29411 29414 - 179.
Promotion of the uptake of PS liposomes and apoptotic cells by a product of growth arrest-specific gene, gas6. J Biochem,Ishimoto Y et al 2000 411 417 - 180.
Both protein S and Gas6 stimulate outer segment phagocytosis by cultured rat retinal pigment epithelial cells. Exp Eye Res,Hall M. O et al 2005 581 591 - 181.
The engulfment process of programmed cell death in caenorhabditis elegans. Annu Rev Cell Dev Biol, andReddien P. W H. R Horvitz 2004 193 221 - 182.
Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol, andRavichandran K. S U Lorenz 2007 964 974 - 183.
CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat Cell Biol, andReddien P. W H. R Horvitz 2000 131 136 - 184.
CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell,Gumienny T. L et al 2001 27 41 - 185.
DOCK180, a major CRK-binding protein, alters cell morphology upon translocation to the cell membrane. Mol Cell Biol,Hasegawa H et al 1996 1770 1776 - 186.
Activation of Rac1 by a Crk SH3-binding protein, DOCK180. Genes Dev,Kiyokawa E et al 1998 3331 3336 - 187.
Rho GTPases and signaling networks. Genes Dev, andVan Aelst L C. D Souza-schorey 1997 2295 2322 - 188.
Opposite effects of rho family GTPases on engulfment of apoptotic cells by macrophages. J Biol Chem,Nakaya M et al 2006 8836 8842 - 189.
Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol, andRiento K A. J Ridley 2003 446 456 - 190.
Integrin beta 1 regulates phagosome maturation in macrophages through Rac expression. J Immunol,Wang Q. Q et al 2008 2419 2428 - 191.
Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr Opin Cell Biol,Stephens L andC Ellson P Hawkins 2002 203 213 - 192.
Inactivation of Cdc42 is necessary for depolymerization of phagosomal F-actin and subsequent phagosomal maturation. J Immunol,Lerm M et al 2007 7357 7365 - 193.
Differential regulation of phagosome maturation in macrophages and dendritic cells mediated by Rho GTPases and ezrin-radixin-moesin (ERM) proteins. Proc Natl Acad Sci U S A,Erwig L. P et al 2006 12825 12830 - 194.
Secretion of a peripheral membrane protein, MFG-E8, as a complex with membrane vesicles. Eur J Biochem,Oshima K et al 2002 1209 1218 - 195.
Impaired involution of mammary glands in the absence of milk fat globule EGF factor 8. Proc Natl Acad Sci U S A, andHanayama R S Nagata 2005 16886 16891 - 196.
Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol, andSanchez-mejorada G C Rosales 1998 521 533 - 197.
Secondary necrosis: the natural outcome of the complete apoptotic program. FEBS Lett,Silva M. T 2010 4491 4499 - 198.
A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis. J Mammary Gland Biol Neoplasia,Stein T et al 2009 99 116 - 199.
Gene expression profiling of cutaneous wound healing. J Transl Med,Deonarine K et al 2007 11 - 200.
Remodeling of the mammary microenvironment after lactation promotes breast tumor cell metastasis. Am J Pathol,Mcdaniel S. M et al 2006 608 620 - 201.
Pregnancy-associated breast cancer and metastasis. Nat Rev Cancer,Schedin P 2006 281 291 - 202.
Microenvironment of the involuting mammary gland mediates mammary cancer progression. J Mammary Gland Biol Neoplasia,Schedin P et al 2007 71 82 - 203.
Review: milk fat globule-EGF factor 8 expression, function and plausible signal transduction in resolving inflammation. Apoptosis,Aziz M et al 2011 1077 1086 - 204.
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv Cancer Res,Linger R. M et al 2008 35 83 - 205.
Interleukin-6 protects human macrophages from cellular cholesterol accumulation and attenuates the proinflammatory response. J Biol Chem,Frisdal E et al 2011 30926 30936 - 206.
A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature,Png K. J et al 2012 190 194